Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-04-27 | Mr. Christopher Paul WillcoxExecutive Officer, Deputy President, Head of Wholesale & Chairman of Investment Management | -5.05k | 38.97k | Sale to Issuer | 7.71 | 14.59k | -25.73% |
| 2026-04-24 | Mr. Christopher Paul WillcoxExecutive Officer, Deputy President, Head of Wholesale & Chairman of Investment Management | -1.36M | 11.18M | Derivative Exercise and Sale | 8.21 | 14.59k | - |
| 2026-04-27 | Mr. Christopher Paul WillcoxExecutive Officer, Deputy President, Head of Wholesale & Chairman of Investment Management | 9.90k | 0.00 | Derivative Exercise and Retained Stock | - | 14.59k | 211.27% |
| 2026-04-27 | Mr. Yutaka NakajimaRepresentative Executive Officer, Deputy President & Director | -4.70k | 36.21k | Sale to Issuer | 7.71 | 682.74k | -0.68% |
| 2026-04-24 | Mr. Yutaka NakajimaRepresentative Executive Officer, Deputy President & Director | -193.02k | 1.58M | Derivative Exercise and Sale | 8.21 | 682.74k | - |
| 2026-04-27 | Mr. Yutaka NakajimaRepresentative Executive Officer, Deputy President & Director | 9.90k | 0.00 | Derivative Exercise and Retained Stock | - | 682.74k | 1.47% |
| 2026-04-27 | Mr. Kentaro OkudaPresident, Group CEO, Representative Executive Officer & Director | -26.71k | 205.90k | Sale to Issuer | 7.71 | 529.19k | -4.80% |
| 2026-04-24 | Mr. Kentaro OkudaPresident, Group CEO, Representative Executive Officer & Director | -325.48k | 2.67M | Derivative Exercise and Sale | 8.21 | 529.19k | - |
| 2026-04-27 | Mr. Kentaro OkudaPresident, Group CEO, Representative Executive Officer & Director | 57.80k | 0.00 | Derivative Exercise and Retained Stock | - | 529.19k | 12.26% |
| 2026-04-27 | Yukiko OzakiSenior MD, Chief HR Officer & Chief Health Officer | -1.47k | 11.31k | Sale to Issuer | 7.71 | 20.99k | -6.53% |
| 2026-04-24 | Yukiko OzakiSenior MD, Chief HR Officer & Chief Health Officer | -2.90k | 23.78k | Derivative Exercise and Sale | 8.21 | 20.99k | - |
| 2026-04-27 | Yukiko OzakiSenior MD, Chief HR Officer & Chief Health Officer | 4.90k | 0.00 | Derivative Exercise and Retained Stock | - | 20.99k | 30.46% |
| 2026-04-27 | Mr. Takumi KitamuraExecutive Officer & Chief Transformation Officer | -4.33k | 33.38k | Sale to Issuer | 7.71 | 145.53k | -2.89% |
| 2026-04-24 | Mr. Takumi KitamuraExecutive Officer & Chief Transformation Officer | -85.91k | 705.29k | Derivative Exercise and Sale | 8.21 | 145.53k | - |
| 2026-04-27 | Mr. Takumi KitamuraExecutive Officer & Chief Transformation Officer | 9.10k | 0.00 | Derivative Exercise and Retained Stock | - | 145.53k | 6.67% |
| 2026-04-27 | Mr. Go SugiyamaExecutive Officer, Deputy President & Head of Banking | -12.92k | 99.63k | Sale to Issuer | 7.71 | 53.81k | -19.36% |
| 2026-04-24 | Mr. Go SugiyamaExecutive Officer, Deputy President & Head of Banking | -42.06k | 345.31k | Derivative Exercise and Sale | 8.21 | 53.81k | - |
| 2026-04-27 | Mr. Go SugiyamaExecutive Officer, Deputy President & Head of Banking | 27.80k | 0.00 | Derivative Exercise and Retained Stock | - | 53.81k | 106.87% |
| 2026-04-27 | Naotaka MinamiSenior MD & Chief Strategy Officer | -1.99k | 15.32k | Sale to Issuer | 7.71 | 29.08k | -6.40% |
| 2026-04-24 | Naotaka MinamiSenior MD & Chief Strategy Officer | -503.00 | 4.13k | Derivative Exercise and Sale | 8.21 | 29.08k | - |
| 2026-04-27 | Naotaka MinamiSenior MD & Chief Strategy Officer | 4.00k | 0.00 | Derivative Exercise and Retained Stock | - | 29.08k | 15.95% |
| 2026-04-24 | Mr. Koji NagaiChairman of the Board | -220.64k | 35.27M | Derivative Exercise and Sale | 159.84 | 512.94k | - |
| 2026-04-27 | Mr. Toshiyasu IiyamaChief of Staff, Executive Officer, Head of Well Growing Institute & Deputy President | -49.45k | 381.26k | Sale to Issuer | 7.71 | 301.66k | -14.08% |
| 2026-04-24 | Mr. Toshiyasu IiyamaChief of Staff, Executive Officer, Head of Well Growing Institute & Deputy President | -60.75k | 498.72k | Derivative Exercise and Sale | 8.21 | 301.66k | - |
| 2026-04-27 | Mr. Toshiyasu IiyamaChief of Staff, Executive Officer, Head of Well Growing Institute & Deputy President | 107.30k | 0.00 | Derivative Exercise and Retained Stock | - | 301.66k | 55.21% |
| 2026-04-27 | Mr. Sotaro KatoExecutive Officer & Chief Risk Officer | 42.30k | 0.00 | Derivative Exercise and Retained Stock | - | 62.77k | 206.60% |
| 2026-04-24 | Mr. Sotaro KatoExecutive Officer & Chief Risk Officer | -35.74k | 293.39k | Derivative Exercise and Sale | 8.21 | 62.77k | - |
| 2026-04-27 | Mr. Sotaro KatoExecutive Officer & Chief Risk Officer | -22.48k | 173.34k | Sale to Issuer | 7.71 | 62.77k | -26.37% |
| 2026-04-27 | Akihito TobariExec. VP & Director | 10.50k | 0.00 | Derivative Exercise and Retained Stock | - | 105.14k | 11.09% |
| 2026-04-27 | Akihito TobariExec. VP & Director | -6.60k | 50.90k | Derivative Exercise and Sale | 7.71 | 105.14k | - |
| 2026-04-27 | Hiroyasu Koikeインサイダー | 5.26k | 0.00 | Derivative Exercise and Retained Stock | - | 113.65k | 4.85% |
| 2026-04-27 | Hiroyasu Koikeインサイダー | -4.74k | 36.58k | Derivative Exercise and Sale | 7.71 | 113.65k | - |
| 2026-04-27 | Takako MoriSenior MD of General Counsel & Joint CCO | 4.12k | 0.00 | Derivative Exercise and Retained Stock | - | 22.93k | 21.92% |
| 2026-04-27 | Takako MoriSenior MD of General Counsel & Joint CCO | -3.78k | 29.14k | Derivative Exercise and Sale | 7.71 | 22.93k | - |
| 2026-04-27 | Akio HoriSenior Managing Director of Group IT & Transformation | 3.15k | 0.00 | Derivative Exercise and Retained Stock | - | 59.34k | 5.60% |
| 2026-04-27 | Akio HoriSenior Managing Director of Group IT & Transformation | -2.95k | 22.76k | Derivative Exercise and Sale | 7.71 | 59.34k | - |
| 2026-04-27 | Hiroyuki MoriuchiExecutive Officer & CFO | 4.82k | 0.00 | Derivative Exercise and Retained Stock | - | 30.68k | 18.66% |
| 2026-04-27 | Hiroyuki MoriuchiExecutive Officer & CFO | -4.38k | 33.74k | Derivative Exercise and Sale | 7.71 | 30.68k | - |
| 2026-04-27 | Yuko HoriuchiSenior Managing Director of Group Finance | 2.77k | 0.00 | Derivative Exercise and Retained Stock | - | 18.45k | 17.67% |
| 2026-04-27 | Yuko HoriuchiSenior Managing Director of Group Finance | -2.63k | 20.28k | Derivative Exercise and Sale | 7.71 | 18.45k | - |
| 2026-04-27 | Mr. Masahiro GotoHead of Executive Management Headquarters & Senior MD | 39.11k | 0.00 | Derivative Exercise and Retained Stock | - | 243.37k | 19.14% |
| 2026-04-27 | Mr. Masahiro GotoHead of Executive Management Headquarters & Senior MD | -30.69k | 236.65k | Derivative Exercise and Sale | 7.71 | 243.37k | - |
| 2026-03-25 | Mr. Masahiro IshizukaIndependent Outside Director | 238.19 | 1.92k | 買い | 8.05 | 10.24k | 2.38% |
| 2026-03-25 | Mr. Shoji OgawaNon-Executive Director | 238.19 | 1.92k | 買い | 8.05 | 58.42k | 0.41% |
| 2026-03-25 | Yukiko OzakiSenior MD, Chief HR Officer & Chief Health Officer | 7.94 | 63.91 | 買い | 8.05 | 17.55k | 0.05% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
